1. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway
   Fei Sun et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
2. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
   Anetta Sulewska et al, 2023, Cells CrossRef
3. Aberrant methylation of mutL homolog 1 is associated with increased risk of non‐small cell lung cancer
   Haochang Hu et al, 2018, Journal of Clinical Laboratory Analysis CrossRef
4. PCDHGA12 methylation biomarker in bronchial washing specimens as an adjunctive diagnostic tool to bronchoscopy in lung cancer
   In Jeong et al, 2018, Oncology Letters CrossRef
5. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC
   Young-Jun Jeon et al, 2018, Nature Communications CrossRef
6. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
   Youji Yan et al, 2019, Oncology Letters CrossRef
7. TUSC3: functional duality of a cancer gene
   Kateřina Vašíčková et al, 2018, Cellular and Molecular Life Sciences CrossRef
8. Overexpression of RASAL1 indicates poor prognosis and promotes invasion of ovarian cancer
   Rui-Xia Chang et al, 2019, Open Life Sciences CrossRef
9. Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression
   Yoichiro Harada et al, 2019, International Journal of Molecular Sciences CrossRef
10. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis
    Shumin Ni et al, 2017, Oncotarget CrossRef
11. TUSC3 methylation in peripheral blood cells as a biomarker for diagnosis of colorectal cancer
    Javad Behroozi et al, 2023, Advanced Biomedical Research CrossRef